Issue Date: March 31, 2014 | Web Date: March 28, 2014
Albany Molecular Research To Aquire Rival Cedarburg
Albany Molecular Research Inc. (AMRI) has agreed to acquire Cedarburg Hauser Pharmaceuticals, a Grafton, Wis.-based contract manufacturer of active pharmaceutical ingredients (APIs), for $41.0 million, including $2.8 million in debt. With the merger last year between Wisconsin-based Cambridge Major Laboratories and AAI Pharma Services, the deal marks the second recent purchase of a Midwest pharmaceutical chemical producer.
AMRI manufactures APIs in Rensselaer, N.Y., but in recent . . .
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society